Chief Editor
Joanna Brougher, Journal of Commercial Biotechnology, United States
Editor at Large
Dr. Arthur Anthony Boni, John R. Thorne Distinguished Career Professor of Entrepreneurship, Emeritus; Tepper School of Business at Carnegie Mellon, United States
Associate Editors
Arlen Meyers, Professor, Department of Otolaryngology, Dentistry and Engineering, University of Colorado Denver, United States
Dr. Thomas J Siepmann, Siepmann IP Consulting, PLLC
Editorial Advisory Board
Mark J. Ahn, Principal, Pukana Partners, Ltd., United States
Dr. Arthur Anthony Boni, John R. Thorne Distinguished Career Professor of Entrepreneurship, Emeritus; Tepper School of Business at Carnegie Mellon, United States
Walter Bratic, Managing Director, Overmont Consulting LLC, United States
Joanna Brougher, Journal of Commercial Biotechnology, United States
Ananda Mohan Chakrabarty, University of Illinois at Chicago, United States
Vijay Chandru, Chairman & CEO, Strand Life Sciences Pvt Ltd, India and Consulting Professor, ISL/EE, Stanford University, United States
James Class, Director, Global Public Policy, Merck, United States
Jeremy Laurence Curnock Cook, Executive Chairman, Bioscience Managers Limited, United Kingdom
Iraj Daizadeh, Senior Manager, Amgen Inc, United States
Mitch DeKoven, Principal, Health Economics & Outcomes Research, Real-World Evidence Solutions, IMS Health, United States
Spencer G. Feldman, Partner, Olshan Frome Wolosky LLP, United States
Sharon Finch, Director, Medius Associates, United Kingdom
Hernan Garrido-Lecca, Chairman and CEO Bioinvest; Professor of Economics and Public Policy, Universidad de San MartÃn de Porres, Lima Peru and Former Minister of Health, Peru
Dave Jensen, Managing Director, Kincannon & Reed Global Executive Search, United States
Alan Jonason, Senior Analyst, Clearpoint Strategy Group LLC, United States
Kenneth Kaitin, Director, Tufts Center for the Study of Drug Development and Professor of Medicine, Tufts University School of Medicine, United States
John Khong, Owner, Niche Medical, J & M Technologies, Cell Sciences; Adjunct faculty, LKC Business School, Singapore management University, Singapore
Thomas J. Kowalski, Attorney at Law, Vedder Price P.C., United States
Leonard Lerer, Sudarskis & Partners, United Arab Emirates
Weijun Li, Senior Research Scientist, Global Biological Development, Bayer HealthCare Pharmaceuticals, United States
Bryan A. Liang, Professor of Anesthesiology & Director San Diego Center for Patient Safety, University of California San Diego School of Medicine; Professor of Law & Executive Director, Institute of Health Law Studies, California Western School of Law, United States
Ken Malone, Principal, Early Charm Ventures
Henry I. Miller, Senior Fellow, Pacific Research Institute, San Francisco, California, United States
Dr. Stefan Michael Miller, Partner, Kirkland & Ellis LLP, United States
Sudha Nair, Director, Global Business Development, Apotex Fermentation Inc., Canada
Robin Nott, Chair of the Laws Committee, Licensing Executives Society Britain and Ireland, United Kingdom
Mark Paris, Director, Bioinformatics & Molecular Biology Vaccinex, Inc.
Peter Pitts, President, Center for Medicine in the Public Interest
Meir Perez Pugatch, Managing Director Pugatch Consilium; Chair, Division of Health Systems Administration, School of Public Health, University of Haifa, Israel
Anthony J Russo, Chairman and CEO, Russo Partners, United States
Gene Rzucidlo, Partner at Hershkovitz & Associates
Stephen M. Sammut, Senior Fellow, Wharton Health Care Systems and Entrepreneurial Programs and Venture Partner, Burrill & Company, United States
Simon Shohet, Practice Director, Pope Woodhead & Associates Ltd, United Kingdom
Grant H Skrepnek, Associate Professor, The University of Oklahoma Health Sciences Center, United States
Ernest Smith, Senior Vice President of Research & Chief Scientific Officer, Vaccinex, Inc.
Anthony Stevens, Director, Medical Options, United Kingdom
Philip Neal Sussman, Managing Partner, The Channel Group LLC, United States
Michael Weiner, CEO, Technology Innovations, United States
Michael Vitale, Director of Commercialisation, Monash Asia-Pacific Centre for Science and Wealth Creation, Monash University, Australia
Publisher
Yali Friedman, Journal of Commercial Biotechnology